Related Experiment Video
Updated: Jun 5, 2026
Quantification of Immunostained Caspase-9 in Retinal Tissue
Published on: July 25, 2022
Caspase inhibitors protect against NMDA-mediated retinal ganglion cell death
Frank Schuettauf1, Thomas Stein, Tomasz J Choragiewicz
1Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Background:
Apoptosis is a major mechanism of cell death in glutamate-induced excitotoxicity and caspases as the executors of apoptosis play an important role in the development of various central nervous system and eye diseases. We studied the involvement of certain caspases in excitotoxic retinal ganglion cell death, which was experimentally induced in Brown Norway Rats by application of the glutamate receptor agonist N-methyl-D-aspartate (NMDA).
Methods:
Animals were injected intravitreally with one of six caspase inhibitors (against caspases 1, 3, 4, 6, 8 and 9). Seven hours later, NMDA or phosphate-buffered saline as a control was injected intravitreally into the respective eyes. The neuroprotective potential against NMDA toxicity was assessed by retinal ganglion cell quantification. Additionally, wholemount TUNEL was performed.
Results:
Statistical analysis revealed significant neuroprotective effects for the inhibitors of caspases 3, 6, 8 and 9, but not for those of caspases 1 and 4. The inhibitors of caspases 6 and 9 showed greater neuroprotective potential than those of caspases 3 and 8, although cell death was not entirely averted in any case. Results of ganglion cell counts were confirmed for the most pronounced treatment groups using wholemount TUNEL.
Conclusion:
Excitotoxic retinal ganglion cell death after NMDA injection is mediated mainly through apoptosis, whereby extrinsic as well as intrinsic pathways of caspase activation play a role.
Insights
Inhibiting specific caspases, particularly caspases 6 and 9, protected retinal ganglion cells from N-methyl-D-aspartate (NMDA) induced excitotoxicity, suggesting apoptosis pathways are key in these eye diseases.
Area of Science:
- Neuroscience
- Ophthalmology
- Cell Biology
Background:
- Apoptosis is a critical cell death pathway in glutamate excitotoxicity.
- Caspases, as apoptosis executors, are implicated in central nervous system and eye diseases.
- Retinal ganglion cell (RGC) death is a concern in various ocular pathologies.
Purpose of the Study:
- To investigate the role of specific caspases in excitotoxic RGC death.
- To evaluate the neuroprotective potential of caspase inhibitors against N-methyl-D-aspartate (NMDA) induced retinal injury.
Main Methods:
- Experimental induction of excitotoxicity in Brown Norway Rats using NMDA.
- Intravitreal administration of inhibitors targeting caspases 1, 3, 4, 6, 8, and 9.
- Assessment of RGC survival via quantification and wholemount TUNEL staining.
Main Results:
- Significant neuroprotection was observed with inhibitors of caspases 3, 6, 8, and 9.
- Caspase 6 and 9 inhibitors demonstrated superior neuroprotective effects compared to caspase 3 and 8 inhibitors.
- While effective, caspase inhibition did not completely prevent NMDA-induced RGC death.
Conclusions:
- NMDA-induced RGC death is primarily mediated by apoptosis.
- Both extrinsic and intrinsic caspase activation pathways contribute to excitotoxic RGC death.
- Targeting specific caspases offers a potential therapeutic strategy for excitotoxic retinal injury.
